KEROS THERAPEUTICS, INC.
99 Hayden Avenue, Suite 120, Building E
Lexington, Massachusetts 02421
April 3, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Ms. Julia Griffith |
| Mr. Dietrich King |
| Ms. Christie Wong |
| Mr. Brian Cascio |
| RE: | Keros Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-237212 |
Acceleration Request
Requested Date: Tuesday, April 7, 2020
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Keros Therapeutics, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on Tuesday, April 7, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant’s counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Ryan Sansom and Esther Cho of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Ryan Sansom of Cooley LLP, counsel to the Registrant, at (617) 937-2335, or in his absence, Esther Cho at (617) 937-2354.
[Signature Page Follows]
| Very truly yours,
KEROS THERAPEUTICS, INC. | ||
| By: | /s/ Jasbir Seehra | |
| Name: | Jasbir Seehra, Ph.D. | |
| Title: | Chief Executive Officer | |
| cc: | Jennifer Lachey, Keros Therapeutics, Inc. |
Marc A. Recht, Cooley LLP
Ryan S. Sansom, Cooley LLP
Brandon Fenn, Cooley LLP
Esther Cho, Cooley LLP
Peter N. Handrinos, Latham & Watkins LLP
Nathan Ajiashvili, Latham & Watkins LLP
[Company Signature Page to Acceleration Request]